Clinical Research News
-
I-Mab Biopharma collaborates with Roche for combination therapy
Clinical Research | News | 0 Comment | 11 Apr, 2019
I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of potential first-in-class and best-in-class biologics in immuno-oncology and aut...Read more
-
George Clinical establishes new presence in Singapore
Clinical Research | News | 0 Comment | 10 Apr, 2019
George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in Asia with the addition of a new presence in Singapore. The...Read more
-
NIH begins first-in-human trial of a universal influenza vaccine candidate
Clinical Research | News | 0 Comment | 05 Apr, 2019
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response ...Read more
-
Veeda Clinical Research Achieves ISO 27001:2013 Certification
Clinical Research | News | 0 Comment | 03 Apr, 2019
India's leading independent CRO, Veeda Clinical Research Pvt. Ltd. has announced that Bureau Veritas has awarded the ISO 27001:2013 Certification to Veeda Clinical Resea...Read more
-
Veeda Clinical Research successfully completes third inspection by NPRA
Clinical Research | News | 0 Comment | 27 Mar, 2019
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmedabad) and Bioanalytical facilities (Insignia, Ahmedabad) have successfully compl...Read more
-
Eisai starts Phase III clinical trial for Alzheimer's drug
Clinical Research | News | 0 Comment | 25 Mar, 2019
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer's disease...Read more
-
WCG introduces a transformational solution for clinical research sites
Clinical Research | News | 0 Comment | 20 Mar, 2019
WIRB-Copernicus Group has introduced WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and profitability of clinical research for institutions and independent r...Read more
-
Clinical Research | News | 0 Comment | 18 Mar, 2019
ImmunogenX has announced the initiation of a Phase 2 clinical trial (named Celiac Shield), sponsored by the National Institutes of Health’s (NIH) National Center for Complementar...Read more
-
Clinical Research | News | 0 Comment | 15 Mar, 2019
Bayer presented results from the CHICO part (CHagas disease In Children treated with NifurtimOx) of the phase III clinical study of investigational nifurtimox in pediatric patients with Cha...Read more
-
Alvotech enrolls first patient for Ph III study involving Biosimilar version of HUMIRA
Clinical Research | News | 0 Comment | 14 Mar, 2019
Global biopharmaceutical company Alvotech has announced that it has enrolled the first patient in its Phase III clinical study (ALVOPAD PS) involving AVT02, Alvotech's HUMIRA biosimilar can...Read more
-
Kezar Life Sciences to test a new drug formulation of KZR-616
Clinical Research | News | 0 Comment | 07 Mar, 2019
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity...Read more
-
Dr Albers receives the distinguished Clinical Research Achievement Award for stroke research
Clinical Research | News | 0 Comment | 07 Mar, 2019
iSchemaView, the worldwide leader in advanced imaging for stroke care and research, is proud to announce that iSchemaView co-founder Dr. Gregory Albers has received the highly respected Dis...Read more
-
Exicure announces dosing of first patient in Ph1b/2 immuno-oncology trial
Clinical Research | News | 0 Comment | 25 Feb, 2019
Exicure, a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs and a pioneer in gene regulatory and immunotherapeutic drugs utiliz...Read more
-
Foresee Pharma announces topline results of FP-001 LMIS in prostate cancer
Clinical Research | News | 0 Comment | 22 Feb, 2019
Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange has announced that the topline results of FP-001 LMIS (Leuprolide Mesylate Injectable ...Read more
-
Enzychem Lifesciences completes Stage 1 patient enrollment in Ph2 CRIOM study
Clinical Research | News | 0 Comment | 22 Feb, 2019
Enzychem Lifesciences, a global biopharmaceutical company headquartered in Seoul, Korea which is dedicated to developing new drugs and APIs (Active Pharmaceutical Ingredients) has announced...Read more
-
Owlstone Medical partners with Shanghai Renji Hospital
Clinical Research | News | 0 Comment | 25 Feb, 2019
Owlstone Medical, a diagnostics company developing a breathalyzer for applications in early disease detection and precision medicine, and Renji Hospital have announced a collaboration to co...Read more
-
Sosei Heptares initiates new clinical development programme
Clinical Research | News | 0 Comment | 22 Feb, 2019
Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030310 in a Phase I clinical study, marking the start of a new in-house ...Read more
-
Mallinckrodt presents analysis results for Therakos against aGvHD
Clinical Research | News | 0 Comment | 21 Feb, 2019
Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its company-sponsored, Phase 3, single-arm, open-label, multi-center study asse...Read more
